xAnts

xAnts

es-LA

The promise of RAD51 testing in tailoring treatment strategies in early breast cancer

2025-01-13

salud

The promise of RAD51 testing in tailoring treatment strategies in early breast cancer

This work received funding from ERA-NET Cofund (Era PerMed), Instituto de Salud Carlos III (ISCIII), and co-funded by the European Union and the Asociación Española Contra el Cáncer (AECC). Reference Guillermo Villacampa, Alba Llop-Guevara, Natalie . Leer más

Recomendaciones